Since SRC and EGFR appear to cooperate to increase tumorigenicity, dual inhibition of SRC and EGFR has been proposed, such as in head and neck squamous cell carcinoma and colorectal cancer [352,353]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.